NEW DELHI: The Competition Commission of India (CCI), India’s fair trade regulator, has locked its sights on unfair practices in the country’s billion-dollar pharmaceuticals and healthcare sectors, calling for proposals to study the nature and magnitude of the problem. The decision comes amid concerns of a continued nexus between companies, doctors and hospitals that keeps patients from accessing high quality, affordable treatment here.

The body has submitted a request for proposals ..READ MORE

Leave a Comment